@FiercePharma: Biotechs trumpet pandemic vaccine deals and data as the H7N9 bird flu threat grows. Story from FierceVaccines | Follow @FiercePharma
@TracyStaton: Two top stories at FiercePharma yesterday are both RE Novartis job cuts. Swiss, with rehires (Story) and New York, with Novartis plant closing by 2017 (Story) | Follow @TracyStaton
@EricPFierce: Closing of U.S. Lonza plant took a toll on its sales last quarter as expiring contracts were not renewed. Story from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: We're taking nominations for the 25 most influential people in biopharma for our annual report. Submit them here. Survey | Follow @CarlyHFierce
> Baxter's ($BAX) fourth-quarter profits topped analyst estimates, thanks to heightened demand for its hemophilia treatments. Report
> Valeant Pharmaceuticals ($VRX) said it may buy back as much as $1.5 billion worth of its notes and shares. Report
> Teva Pharmaceutical Industries ($TEVA) inked a deal with MDxHealth to commercial its cancer diagnostic tests in Israel. Report
> Goldman Sachs said it had placed a 5% stake in Spain's Almirall; sold by Grupo Plafin, the stake sold at €11.75 per share, or €102 million ($138 million). Report
> India's Biocon saw its shares slump today after reporting earnings that fell short of some expectations. Report
@FierceMedDev: In 2013, eNeura won de novo approval in the U.S. for its anti-migraine device. Report | Follow @FierceMedDev
@MarkHFierce: Stryker grew net sales by 5.6% in Q4. Release | Follow @MarkHFierce
@MichaelGFierce: Statins delivered with HDL nanoparticles reduce risk of second heart attack, stroke. Story from FierceDrugDelivery | Follow @MichaelGFierce
@EmilyWFierce: Quest Diagnostics inks $570M Solstas deal. Story | Follow @EmilyWFierce
> Covidien opens an Indian medical training center with a med tech focus. Article
> Varian touts emerging markets as looming Medicare changes take a toll. News
> Quest Diagnostics will pay $570M for another laboratory testing outfit. Item
> For Stryker, acquisitions began to generate financial benefits in late 2013. More
> Medtronic wins patent loss reversal in U.S. Supreme Court. Report
Biotech News
@FierceBiotech: U.K. to digitize patient health records and sell access to biopharma researchers. Story from FierceBiotech IT | Follow @FierceBiotech
@JohnCFierce: U.K. group looks to ignite a Boston-style biotech comeback. More | Follow @JohnCFierce
@DamianFierce: Reminder that FierceBiotech's annual list of the most influential people in biopharma is now (somewhat) democratic. More | Follow @DamianFierce
@EmilyMFierce: This map of vaccine-preventable diseases is pretty striking. Map | Follow @EmilyMFierce
> Can Roche's old R&D campus attract biotechs? Item
> Amgen notches another PhIII win for its PCSK9 blockbuster hopeful. News
> Pfizer's pain med clears PhIII as long-delayed Remoxy waits in the wings. Report
> J&J carves out a new group to develop drugs for poor countries. Article
> Buzz: Back from the ER, a wounded Ariad spurs a fresh round of takeover rumors. More
Pharma Manufacturing News
> J&J consumer health boosts results, even without key plant. Story
> Par bolsters its sterile manufacturing with a $490M deal to grab JHP. Story
> New York plant that makes Diovan is next on Novartis' shutdown list. Story
> Glaxo is investing $200M in additions to its U.K. site. Story
> Lilly gets ready for track-and-trace in U.S. Item
> Lonza's pharma unit sales suffer as it closes U.S. biologics plant. Article
Vaccines News
> How vaccines helped India defeat polio while Pakistan became a reservoir for the virus. Story
> Study: Tightening vaccine exemption laws would cut cases of whooping cough. Story
> Map of vaccine-preventable diseases shows the scale of problems facing the West. Story
> Biotechs trumpet pandemic vaccine deals and data as the H7N9 bird flu threat grows. Story
> NIH backs New York MERS-CoV vaccine development program. Story
> The political causes of the Syrian polio crisis. Item
And Finally... Fish oil may help preserve brain cells, a study found. Report